Veterinary Medicines

BOVICEF DC 250 mg Intramammary Suspension for Cattle

Not authorised
  • Cefalonium dihydrate
Download as PDF

Product identification

Medicine name:
BOVICEF DC 250 mg Intramammary Suspension for Cattle
BOVICEF DC 250 mg Intramammary Suspension for Cattle
Active substance:
  • Cefalonium dihydrate
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cefalonium dihydrate
    269.63
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        96
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51DB90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Ireland
Package description:
  • Single dose 3g white polyethylene intramammary syringe with a polyethylene cap. Pack sizes: 120 intramammary syringes in a bucket. All pack sizes contain cleaning towels.
  • Single dose 3g white polyethylene intramammary syringe with a polyethylene cap. Pack sizes: 24 intramammary syringes in a carton. All pack sizes contain cleaning towels.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • CROSS VETPHARM GROUP Ltd.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10387/003/001
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0530/001